- Home
- IMPP vs OPTN Comparison
IMPP vs OPTN Comparison
Compare IMPP & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMPP
- OPTN
- Stock Information
- Founded
- IMPP 1981
- OPTN 2010
- Country
- IMPP Greece
- OPTN United States
- Employees
- IMPP N/A
- OPTN N/A
- Industry
- IMPP Marine Transportation
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- IMPP Consumer Discretionary
- OPTN Health Care
- Exchange
- IMPP Nasdaq
- OPTN Nasdaq
- Market Cap
- IMPP 97.8M
- OPTN 78.4M
- IPO Year
- IMPP N/A
- OPTN 2017
- Fundamental
- Price
- IMPP $2.88
- OPTN $0.45
- Analyst Decision
- IMPP
- OPTN Strong Buy
- Analyst Count
- IMPP 0
- OPTN 3
- Target Price
- IMPP N/A
- OPTN $3.00
- AVG Volume (30 Days)
- IMPP 266.3K
- OPTN 1.2M
- Earning Date
- IMPP 02-11-2025
- OPTN 11-12-2024
- Dividend Yield
- IMPP N/A
- OPTN N/A
- EPS Growth
- IMPP N/A
- OPTN N/A
- EPS
- IMPP 1.51
- OPTN N/A
- Revenue
- IMPP $151,150,129.00
- OPTN $75,672,000.00
- Revenue This Year
- IMPP N/A
- OPTN $13.42
- Revenue Next Year
- IMPP $36.53
- OPTN $52.99
- P/E Ratio
- IMPP $1.91
- OPTN N/A
- Revenue Growth
- IMPP N/A
- OPTN 5.13
- 52 Week Low
- IMPP $2.17
- OPTN $0.32
- 52 Week High
- IMPP $4.59
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- IMPP 21.85
- OPTN 39.55
- Support Level
- IMPP $2.82
- OPTN $0.42
- Resistance Level
- IMPP $3.02
- OPTN $0.57
- Average True Range (ATR)
- IMPP 0.12
- OPTN 0.05
- MACD
- IMPP 0.01
- OPTN 0.00
- Stochastic Oscillator
- IMPP 15.22
- OPTN 26.39
About IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil and jet fuel, as well as edible oils and chemicals.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.